Equine Influenza Virus (EIV) Nucleic Acid Test Kit (Lyophilized)

Clinical Applications

1. Rapid and Accurate Diagnosis: The EIV nucleic acid detection reagent can quickly identify the presence of the virus in horses with suspected influenza symptoms. By detecting the specific nucleic acid sequences of EIV, veterinarians can confirm the diagnosis accurately, even in the early stage of infection when symptoms may be mild or non - specific. This allows for timely initiation of appropriate treatment, such as antiviral medications and supportive care, to reduce the severity of the disease and speed up the recovery process.

2. Epidemic Prevention and Control: In horse - concentrated areas like large - scale horse farms, equestrian centers, and horse racing tracks, regular screening using the EIV nucleic acid detection reagent is crucial. Identifying infected horses early and isolating them promptly can effectively prevent the spread of the virus within the horse population. Additionally, during an outbreak, the reagent can be used to quickly assess the scope of the epidemic, enabling the implementation of strict biosecurity measures, such as quarantine, disinfection, and restriction of horse movement, to contain the spread of EIV.

3. Pre - event and Transportation Screening: Before important equine events, such as international horse competitions or horse sales, horses are often screened with the EIV nucleic acid detection reagent. This ensures that only healthy horses participate in the event, preventing the introduction and spread of the virus among horses from different regions. Similarly, when horses are transported for various reasons, pre - transportation screening can help avoid the transmission of EIV during transit and protect the health of horses at the destination.

4. Research and Surveillance: The EIV nucleic acid detection reagent provides valuable support for scientific research on the virus. It helps researchers study the genetic characteristics, evolution, and transmission patterns of EIV. By analyzing a large number of clinical samples, they can better understand the virus's behavior and develop more effective prevention and control strategies. In addition, continuous surveillance using the reagent can monitor the prevalence and genetic variation of EIV in different regions and horse populations, providing important data for early warning and response to potential epidemics.